Next-Gen Biosafety Masterclass
11 Rue Watt, BioPark, Bâtiment B, 75013 Paris, France
PathoQuest is pleased to announce the upcoming Next-Gen Biosafety Masterclass:
"Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use"
🕣 Registration: 08:30–09:00 CEST
🗣️ Presentations: 09:00–17:00 CEST
🍸 Networking Cocktail Reception: 17:00–18:00 CEST
Join us for a full day of expert presentations and discussions. Explore the agenda below:
Welcome & Strategic Context
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest
Horst Ruppach – Executive Director, Scientific & Portfolio, Global Biologics, Charles River Laboratories
Biologics: Market Trends, Pipeline Dynamics, and Industrial Production
Elsa Kress – Head of Business Development, MabDesign
European Regulations on the Detection of Viral Adventitious Agents Using Next Generation Sequencing (NGS)
Johannes Bluemel – Head of the Viral Safety Section, Paul-Ehrlich-Institut
Global Overview of the Implementation and Regulatory Acceptance of NGS for Vaccine Safety Testing
Laura Viviani – Founder and Consultant, SciEthiQ
Characterization of Starting Materials for the Production of Viral Therapeutics Using Next Generation Sequencing (NGS)
Michael Ruffing – Global Development CMC Biologicals, Boehringer Ingelheim
Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
Jens Modrof – Director of Operations, Global Pathogen Safety, Takeda
Agency Expectations and the Use of NGS: Have They Finally Aligned?
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest
Horst Ruppach – Executive Director, Scientific & Portfolio, Global Biologics, Charles River Laboratories
The Power and Challenges of NGS in Viral Vector Identity Assays
Nadia Avenier – Head of the Analytical Expertise Center, Yposkesi / an SK pharmteco company
Industry Presentation – Title to Be Confirmed (TBC)
Carine Logvinoff – Global Analytical Virology Expert, Sanofi
Adoption of NGS for Viral Safety Testing in Exosome Manufacturing
Huilan Lin – Principal Scientist, Capricor Therapeutics
Ask the Experts – Interactive Session
All Speakers
Closing Remarks & Networking Cocktail
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest

